help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on July 14, 2005
Molecular Endocrinology, doi:10.1210/me.2004-0408
Molecular Endocrinology Vol. 0, No. 2005 200404081-
doi:10.1210/me.2004-0408
Copyright © 2005 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
19/12/2964    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiao, F.
Right arrow Articles by Klug, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiao, F.
Right arrow Articles by Klug, J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Compound via MeSH
*Substance via MeSH

Submitted on October 13, 2004
Accepted on July 8, 2005

Secretoglobin 2A1 is under selective androgen control mediated by a peculiar binding site for Sp family transcription factors

Fei Xiao, Andreas Mirwald, Maria Papaioannou, Aria Baniahmad, and Jörg Klug*

Institut für Anatomie und Zellbiologie, Justus-Liebig-Universität Giessen (F.X., J.K.), D-35385 Giessen, Germany; Institut für Molekularbiologie und Tumorforschung (A.M.), Philipps-Universität Marburg, D-35033 Marburg, Germany; Institut für Humangenetik und Anthropologie, Klinikum der Friedrich-Schiller-Universität Jena, 07740 Jena (M.P., A.B.)

* To whom correspondence should be addressed. E-mail: joerg.klug{at}anatomie.med.uni-giessen.de.

Human secretoglobin (SCGB) 2A1 (or lipophilin C, lacryglobin, mammaglobin B) is a small protein of unknown function that forms heterodimers with secretoglobin 1D1 (lipophilin A) in tears and is expressed in the prostate. Here we show that SCGB 2A1 is under androgen control in the androgen responsive prostatic cell line LNCaP and can be induced more than 20-fold by dihydrotestosterone. Only 6 h after androgen treatment a strong DNase I hypersensitive site (DHS) is induced in the proximal promoter within chromatin. Within the boundaries of this DHS a minimal 32 bp peculiar dimeric inverted repeat variant GC box (dim-IR-GA box) was found to confer androgen but not glucocorticoid responsiveness in gene transfer experiments. Mutations of both GA boxes that abolish binding of Sp1 and Sp3 also abrogate the androgen response. In an electrophoretic mobility shift assay (EMSA) the DNA binding domain of the androgen receptor (AR) was not able to bind directly to the dim-IR-GA box. But AR is functionally required for the hormone response because induction can be inhibited with the nonsteroidal antagonist bicalutamide. Chromatin immunoprecipitation experiments demonstrated that AR is recruited to the proximal promoter 10 min after androgen treatment. Therefore we propose that SCGB 2A1 represents a new class of androgen target genes that are purely under indirect AR control mediated by DNA-bound Sp factors.


Key words: Secretoglobin 2A1 • lipophilin C • androgen control • Sp1 • Sp3 • NF1 • NF-Y

NURSA Molecule Pages Link:

Nuclear Receptors:   ERα  |  ERβ  |  AR
Coregulators:   GRIP1
Ligands:   Dexamethasone  |  17β-Estradiol  |  Dihydrotestosterone  |  Diethylstilbestrol  |  4-Hydroxytamoxifen  |  Raloxifene  |  Bicalutamide  |  R1881



This article has been cited by other articles:


Home page
EndocrinologyHome page
M. H. Hong, H. Sun, C. H. Jin, M. Chapman, J. Hu, W. Chang, K. Burnett, J. Rosen, A. Negro-Vilar, and J. N. Miner
Cell-Specific Activation of the Human Skeletal {alpha}-Actin by Androgens
Endocrinology, March 1, 2008; 149(3): 1103 - 1112.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
P. J I Ellis, R. A Furlong, S. J Conner, J. Kirkman-Brown, M. Afnan, C. Barratt, D. K Griffin, and N. A Affara
Coordinated transcriptional regulation patterns associated with infertility phenotypes in men
J. Med. Genet., August 1, 2007; 44(8): 498 - 508.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
U. Moehren, M. Papaioannou, C. A. Reeb, W. Hong, and A. Baniahmad
Alien Interacts with the Human Androgen Receptor and Inhibits Prostate Cancer Cell Growth
Mol. Endocrinol., May 1, 2007; 21(5): 1039 - 1048.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
M. Lacroix
Significance, detection and markers of disseminated breast cancer cells
Endocr. Relat. Cancer, December 1, 2006; 13(4): 1033 - 1067.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society